The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
TeliMET NSCLC-04: A phase 2, open-label, randomized, global study of 2 telisotuzumab vedotin regimens in patients with previously treated c-Met protein–overexpressing, locally advanced/metastatic non-squamous EGFR wildtype non-small cell lung cancer.
 
Alona Zer
Honoraria - AstraZeneca; Bristol-Myers Squibb; Johnson & Johnson/Janssen; MSD; Pfizer; Roche
Consulting or Advisory Role - BeiGene; Boehringer Ingelheim; Gilead Sciences; MSD; Roche
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Roche
Other Relationship - Beyond Air
 
Christine Ratajczak
Employment - Abbvie
Stock and Other Ownership Interests - AbbVie
 
Hephzibah Adamu
Employment - AbbVie
Stock and Other Ownership Interests - AbbVie
 
Shilpen Patel
Employment - AbbVie
Stock and Other Ownership Interests - AbbVie
 
Zhuangzhuang Liu
Employment - AbbVie
Stock and Other Ownership Interests - AbbVie
 
Summer Xia
Employment - Abbvie; Lilly
Stock and Other Ownership Interests - Abbvie; Lilly
Travel, Accommodations, Expenses - Abbvie
 
Nancy Zhang
Employment - AbbVie
Stock and Other Ownership Interests - AbbVie